These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 19879442)
61. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Kowalski ML; Pawliczak R; Wozniak J; Siuda K; Poniatowska M; Iwaszkiewicz J; Kornatowski T; Kaliner MA Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):391-8. PubMed ID: 10673176 [TBL] [Abstract][Full Text] [Related]
62. [Intranasal provocation with lysine acetylsalicylic acid]. Wellbrock M; Mertens J; Cornelius M; Brasch J HNO; 1993 Dec; 41(12):577-81. PubMed ID: 8125801 [TBL] [Abstract][Full Text] [Related]
63. Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis. Lee JY; Simon RA Curr Allergy Asthma Rep; 2006 May; 6(3):183-4. PubMed ID: 16579867 [No Abstract] [Full Text] [Related]
64. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059 [TBL] [Abstract][Full Text] [Related]
65. Mechanisms of aspirin desensitization. Burnett T; Katial R; Alam R Immunol Allergy Clin North Am; 2013 May; 33(2):223-36. PubMed ID: 23639710 [TBL] [Abstract][Full Text] [Related]
66. Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future. Kennedy JL; Stoner AN; Borish L Am J Rhinol Allergy; 2016 Nov; 30(6):407-413. PubMed ID: 28124651 [TBL] [Abstract][Full Text] [Related]
67. [Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge]. Rubinsztajn R; Wrońska J; Chazan R Pol Arch Med Wewn; 2003 Aug; 110(2):849-54. PubMed ID: 14682223 [TBL] [Abstract][Full Text] [Related]
68. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD). Simon RA; Dazy KM; Waldram JD Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486 [TBL] [Abstract][Full Text] [Related]
69. [Chronic rhinosinusitis and aspirin intolerance]. Leunig A; Braunschweig F; Havel M; Markmann S; Kramer M; Menz G MMW Fortschr Med; 2009 Jan; 151(5):44-5. PubMed ID: 19391414 [No Abstract] [Full Text] [Related]
70. Aspirin treatment of patients with aspirin intolerance, asthma, and nasal polyps. Feldweg AM; Horan RF Allergy Asthma Proc; 2001; 22(6):377-82. PubMed ID: 11775396 [TBL] [Abstract][Full Text] [Related]
71. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics. Schmid M; Göde U; Schäfer D; Wigand ME Acta Otolaryngol; 1999 Mar; 119(2):277-80. PubMed ID: 10320091 [TBL] [Abstract][Full Text] [Related]
72. Asthma in children and ASA intolerance. Estrada Rodríguez JL; Florido López JF; Belchi Hernández J; Martín Muñoz F; Díaz Pena JM; García Ara MC; Sastre Domínguez J; Ojeda Casas A J Investig Allergol Clin Immunol; 1993; 3(6):315-20. PubMed ID: 8012649 [TBL] [Abstract][Full Text] [Related]
73. Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity. Cortellini G; Romano A; Santucci A; Barbaud A; Bavbek S; Bignardi D; Blanca M; Bonadonna P; Costantino MT; Laguna JJ; Lombardo C; Losappio LM; Makowska J; Nakonechna A; Quercia O; Pastorello EA; Patella V; Terreehorst I; Testi S; Cernadas JR; ; Dionicio Elera J; Lippolis D; Voltolini S; Grosseto D Allergy; 2017 Mar; 72(3):498-506. PubMed ID: 27732743 [TBL] [Abstract][Full Text] [Related]
74. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Rozsasi A; Polzehl D; Deutschle T; Smith E; Wiesmiller K; Riechelmann H; Keck T Allergy; 2008 Sep; 63(9):1228-34. PubMed ID: 18699939 [TBL] [Abstract][Full Text] [Related]
75. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease. Kowalski ML; Wardzyńska A; Makowska JS Immunol Allergy Clin North Am; 2016 Nov; 36(4):705-717. PubMed ID: 27712765 [TBL] [Abstract][Full Text] [Related]
76. Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs. Laidlaw TM; Cahill KN J Allergy Clin Immunol Pract; 2017; 5(3):537-545. PubMed ID: 28483309 [TBL] [Abstract][Full Text] [Related]
77. Current view on nasal polyps management in Samter's triad patients. Mrówka-Kata K; Czecior E; Kata D; Namysłowski G; Dziechciarz-Werbowska J; Sowa P Otolaryngol Pol; 2012; 66(6):373-8. PubMed ID: 23200555 [TBL] [Abstract][Full Text] [Related]
78. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization. Walters KM; Simon RA; Woessner KM; Wineinger NE; White AA Ann Allergy Asthma Immunol; 2017 Jul; 119(1):71-76. PubMed ID: 28668243 [TBL] [Abstract][Full Text] [Related]
79. Aspirin desensitization in a patient with aspirin sensitivity and chronic idiopathic urticaria. Slowik SM; Slavin RG Ann Allergy Asthma Immunol; 2009 Feb; 102(2):171-2. PubMed ID: 19230473 [No Abstract] [Full Text] [Related]
80. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Sanz ML; Gamboa P; de Weck AL Int Arch Allergy Immunol; 2005 Jan; 136(1):58-72. PubMed ID: 15608437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]